The Effect of Hepatosteatosis on Response to Antiviral Treatment in Patients with Chronic Hepatitis B: A Meta-Analysis

Table 3

Subgroup analysis based on the method used for diagnosis of fatty liver.

Outcome or subgroup	Study	Participants	RR/WMD (weighted mean difference) 95% CI
48W biochemical response	5	325/530	0.864/(0.778, 0.960)	0.007
Histopathology	2	65/120	0.980/(0.720, 1.352)	0.934
Ultrasound B	3	260/410	0.842/(0.754, 0.940)	0.002
48W virological response	7	380/623	0.896/(0.811, 0.989)	0.030
Histopathology	4	120/213	1.002/(0.773, 1.298)	0.987
Ultrasound B	3	260/410	0.866/(0.782, 0.959)	0.006
48W serological response	4	152/296	0.900/(0.661, 1.226)	0.504
Histopathology	3	87/148	0.936/(0.654, 1.340)	0.718
Ultrasound B	1	65/148	0.828/(0.458, 1.498)	0.533

RR: risk ratio; CI: confidence interval.